ImmuCell Corporation (ICCC)

ImmuCell Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.91	3.81	3.76	0.98	5.79	10.19
Cash & Short-Term Investments	7.91	3.81	3.76	0.98	5.79	10.19
Cash Growth	103.65%	1.29%	283.99%	-83.10%	-43.14%	28.18%
Accounts Receivable	3.37	3.42	3.77	2.19	1.76	2.69
Other Receivables	-	0.03	0.04	0.04	0.04	0.03
Receivables	3.37	3.45	3.81	2.23	1.8	2.72
Inventory	9.86	9.27	7.11	7.81	6.04	3.09
Prepaid Expenses	0.43	0.42	0.36	0.45	0.36	0.27
Total Current Assets	21.58	16.94	15.04	11.47	13.99	16.26
Property, Plant & Equipment	26.26	25.45	29.91	32.15	30.64	28
Goodwill	0.1	0.1	0.1	0.1	0.1	0.1
Other Intangible Assets	-	-	0.02	0.04	0.06	0.08
Other Long-Term Assets	0.03	0.04	0.03	0.06	0.08	0.03
Total Assets	47.96	42.53	45.1	43.81	44.86	44.47

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.17	0.79	0.93	0.87	0.73	0.73
Accrued Expenses	-	1.48	1.53	1.23	1.21	0.87
Current Portion of Long-Term Debt	1.38	1.61	1.5	1.43	1.04	0.81
Current Portion of Leases	0.12	0.09	0.43	0.64	0.03	0.11
Current Income Taxes Payable	-	0.01	0.01	0	0	0
Other Current Liabilities	-	0	0.01	0.01	0.06	0.02
Total Current Liabilities	4.68	3.98	4.41	4.2	3.07	2.53
Long-Term Debt	6.52	7.49	9.04	10.54	9.19	8.33
Long-Term Leases	3.99	4.01	4.13	4.08	2.22	1.03
Total Liabilities	15.18	15.48	17.58	18.82	14.48	11.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.91	0.91	0.9	0.78	0.78	0.78
Additional Paid-In Capital	42.39	41.48	40.92	36.36	35.98	35.69
Retained Earnings	-10.47	-15.2	-14.16	-12.01	-6.23	-3.74
Treasury Stock	-0.05	-0.13	-0.14	-0.14	-0.15	-0.16
Shareholders' Equity	32.77	27.06	27.52	24.99	30.38	32.58
Total Liabilities & Equity	47.96	42.53	45.1	43.81	44.86	44.47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.01	13.19	15.1	16.69	12.48	10.27
Net Cash (Debt)	-4.1	-9.39	-11.34	-15.71	-6.69	-0.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.45	-1.04	-1.39	-2.03	-0.86	-0.01
Filing Date Shares Outstanding	9.09	9.05	8.98	7.75	7.75	7.74
Total Common Shares Outstanding	9.09	9.05	8.98	7.75	7.75	7.74
Working Capital	16.9	12.97	10.63	7.27	10.92	13.73
Book Value Per Share	3.61	2.99	3.06	3.22	3.92	4.21
Tangible Book Value	32.68	26.96	27.4	24.86	30.23	32.4
Tangible Book Value Per Share	3.59	2.98	3.05	3.21	3.90	4.19
Land	-	0.52	0.52	0.52	0.52	0.52
Buildings	-	20.9	20.89	20.78	20.05	19.12
Machinery	-	17.96	22.29	21.99	20.08	18.26
Construction In Progress	-	0.53	2.69	2.77	3.67	2.99
Order Backlog	-	9.4	4.4	9.4	2.5	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error